Greater Occipital Nerve Block Alone Versus Dual Nerve Block in Cervicogenic Headache and Occipital Neuralgia
NCT ID: NCT07068451
Last Updated: 2025-07-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
160 participants
INTERVENTIONAL
2020-01-01
2023-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The researchers compared:
One nerve injection (greater occipital nerve block, or GONB), versus
Two nerve injections (GONB plus lesser occipital nerve block, or LONB).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Research Study of Greater Occipital Nerve Block As A Treatment For Prolonged Migraine Attacks
NCT00329732
Comparison of Occipital Nerve and Sphenopalatine Ganglion Blockade
NCT06243874
A Research Study of Greater Occipital Nerve Block as a Treatment for Acute Migraine Attacks
NCT03159000
Comparing Unilateral and Bilateral Proximal GONPRF in Migraine Treatment
NCT06894121
Efficacy of GONB in Patients of Migraine
NCT05679765
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GONB Alone
Patients received a single injection of 1 mL of 2% lidocaine at the greater occipital nerve using a landmark-guided technique.
Greater Occipital Nerve Block (GONB)
A landmark-guided injection of 1 mL of 2% lidocaine administered at the anatomical location of the greater occipital nerve (GON) to treat cervicogenic headache and occipital neuralgia. Performed without corticosteroids or imaging guidance.
GONB + LONB (Dual Block)
Patients receive two injections of 1 mL of 2% lidocaine each at the greater and lesser occipital nerves using a landmark-guided technique.
Combined Greater and Lesser Occipital Nerve Block (GONB + LONB)
Two landmark-guided injections of 1 mL of 2% lidocaine each at the anatomical locations of the greater and lesser occipital nerves. Performed without corticosteroids or imaging, targeting broader nerve involvement in cervicogenic headache and occipital neuralgia.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Greater Occipital Nerve Block (GONB)
A landmark-guided injection of 1 mL of 2% lidocaine administered at the anatomical location of the greater occipital nerve (GON) to treat cervicogenic headache and occipital neuralgia. Performed without corticosteroids or imaging guidance.
Combined Greater and Lesser Occipital Nerve Block (GONB + LONB)
Two landmark-guided injections of 1 mL of 2% lidocaine each at the anatomical locations of the greater and lesser occipital nerves. Performed without corticosteroids or imaging, targeting broader nerve involvement in cervicogenic headache and occipital neuralgia.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
Use of systemic corticosteroids within the past 3 months
Known allergy to lidocaine or other amide-type local anesthetics
Evidence of secondary causes of headache on imaging (e.g., tumor, infection)
Pregnancy or breastfeeding
Active infection at the injection site
Coagulopathy or use of anticoagulant therapy
Significant psychiatric or neurological comorbidities interfering with study participation
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tishreen University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ali Hammed
Dr
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Latakia
Latakia, , Syria
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N/2020-31
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.